BioSpace News Archive

Mablink Bioscience, a company developing the next generation of antibody-drug conjugates (ADC) through its proprietary hydrophilic drug-linker PSARlink™ platform, announces today the completion of a €4 Million Seed financing round led by Elaia Partners and along with Pertinence Invest 2 (Sofimac Innovation advised by Mérieux Equity Partners

PTC Therapeutics, Inc. announced that management will present a company overview at the following conferences

FARMACEUTICALRX (“FARMACEUTICALRX” or the “Company”), the leading natural and organic multistate, vertically integrated medical marijuana operator in the United States, today announced the hiring of organic food and beverage industry veteran Jeffrey Skirvin as the Company’s new Chief Operating Officer (“COO”)

Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, received Health Canada approval for the first and only daily disposable contact lens for vision correction in patients who experience itchy allergy eyes due to allergic conjunctivitis: ACUVUE® Theravision™ with Ketotifen

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will install the digital pathology module of its enterprise imaging solution at Baylor College of Medicine to provide primary diagnostics and archiving of pathology images for the Texas Medical Center in Houston,

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology, today announced that the 52-week results from its pivotal cellulite trial have been accepted for an oral presentation at the American Society for Laser Medicine and Surgery Virtual Annual Conference, held May 15-16, 2021.

Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced the close of the first $15 million of a planned $30 million Series C from a new life sciences investor.

Teva to Present New Analyses of AUSTEDO ® (deutetrabenazine) Tablets and Assessment of Schizophrenia Clinical Outcomes at Upcoming 2021 American Psychiatric Association Annual Meeting Four posters examine the long-term efficacy, safety, and tolerability of AUSTEDO in patients with tardive dyskinesia and a review of clinical outcome measures in schizophrenia

Alydia Health, a commercial-stage medical device company focused on making childbirth safer for all mothers, announced that industry veteran Paul Praino has joined the company as Vice President of Sales.

$2 million grant will fund immune biomarker analysis in Phase 1 clinical study of SQ3370 as well as manufacturing process development SQ3370 is a click-activated protodrug therapy currently in a Phase 1 clinical study in advanced sarcomas and other solid tumors